Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : Nktr save search
Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer
Published: 2023-09-27 (Crawled : 15:30) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 0.75%
H: 1.45%
C: -2.11%
nktr-255 lung cancer group cell collaboration therapeutics study
BigHat Biosciences Completes First Stage of Research Collaboration with Amgen
Published: 2022-01-11 (Crawled : 15:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
research bioscience collaboration
Nykode Therapeutics (Formerly Vaccibody*)) Enters Into Multi-target License and Collaboration Agreement With Regeneron to Develop Innovative Vaccines Against Cancer and Infectious Diseases
Published: 2021-11-23 (Crawled : 09:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: -2.87%
H: 0.18%
C: -0.87%
disease infectious disease collaboration cancer vaccine license therapeutics
Nektar Announces New Clinical Collaboration with Merck KGaA Darmstadt, Germany and Pfizer Inc. to Combine NKTR-255, a Novel Interleukin-15 Agonist, with Avelumab in the JAVELIN Bladder Medley Study
Published: 2021-09-21 (Crawled : 14:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 2.57%
H: 6.44%
C: 5.73%
germany collaboration bladder
Exelixis Announces Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Evaluate XL092 in Combination with Immuno-oncology Therapies in Advanced Solid Tumors
Published: 2021-06-14 (Crawled : 17:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.03%
H: 0.19%
C: -0.04%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 0.62%
H: 2.31%
C: -0.23%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: 0.48%
H: 1.08%
C: -1.43%
solid tumors collaboration trial therapy
Biolojic Design Enters a Research Collaboration and License Option Agreement with Nektar Therapeutics to Develop Computationally Designed Antibodies Against a Novel Target for the Potential Treatment of Autoimmune Disease
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 0.04%
H: 1.36%
C: -1.49%
disease treatment collaboration computational license research antibody potential designation
Nektar Secures Collaborative Deal with SFJ to Advance Head and Neck Cancer Therapy
Published: 2021-02-17 (Crawled : 20:00) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 11.31%
H: 7.0%
C: 1.84%
therapy cancer collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.